quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:00:35·37d
SECFiling
Crescent Biopharma Inc. logo

SEC Form 424B3 filed by Crescent Biopharma Inc.

CBIO· Crescent Biopharma Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • CBIO
    Crescent Biopharma Inc.
    Health Care

Recent analyst ratings

  • Jan 28UpdatePiper Sandler$35.00
  • Jan 21UpdateGuggenheim$35.00
  • Aug 25UpdateJefferies$26.00
  • Aug 11UpdateH.C. Wainwright$25.00
  • Jul 14UpdateWedbush$27.00
  • Jun 25UpdateStifel$28.00

Related

  • SEC2d
    SEC Form DEFA14A filed by Crescent Biopharma Inc.
  • SEC2d
    SEC Form DEFA14A filed by Crescent Biopharma Inc.
  • SEC2d
    SEC Form DEF 14A filed by Crescent Biopharma Inc.
  • PR27d
    Crescent Biopharma Announces Grants of Inducement Awards
  • PR48d
    Crescent Biopharma Announces Grants of Inducement Awards
  • SEC51d
    SEC Form EFFECT filed by Crescent Biopharma Inc.
  • SEC52d
    SEC Form POS AM filed by Crescent Biopharma Inc.
  • SEC56d
    SEC Form 424B3 filed by Crescent Biopharma Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022